[NVIC] UK Docs Attack Wakefield

[Guest guest]

E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#8122

* * * * * * * * * * * * * * * * * * * * * * *

" Protecting the health and informed consent rights of children since 1982. "

============================================================================

==============

Barbara Loe Fisher Note:

In 1997, Andy Wakefield, M.D. was a guest speaker at the First

International Public Conference on Vaccination sponsored by the National

Vaccine Information Center in Washington, D.C. The title of his talk was

" Measles Virus and Measles Vaccine: Lessons to be Learned " and he made his

presentation despite threats from people in high places in the medical

profession in Great Britain and elsewhere who warned him his career was on

the line.

Although Kathi and I assured him we would understand and the

audience would understand if he had to withdraw in order to save his career,

Dr. Wakefield declined the offer. Refusing to be bullied by those acting

more like hit men in a medical mafia than healers, he said " I will not live

my life in fear. " He believed what he had discovered about measles virus,

MMR vaccine, intestinal bowel disease and and autism was something that had

to be discussed publicly to prevent more children from being harmed.

From the moment Andy Wakefield stood his ground and said " I will not live

my life in fear " and then went on to talk with me about how important it was

to stand up for the truth even though you risk your life to do it, I knew he

was an extraordinary individual. I knew he would make history but pay a

terrible price for it.

During the past 25 years of work to prevent vaccine injuries and deaths

through public education and defend the informed consent ethic, I have seen

doctors who tell the truth about vaccine risks be viciously attacked by

their colleagues in government, industry and academia. The attacks are both

professional and personal and, with surgical precision, the goal is to

evisicerate rather than simply stun the victim. It is an ugly process and it

has a distinctly Spanish Inquisition flavor to it.

Undaunted, Dr. Wakefield has continued to conduct his humanitarian

research into the biological mechanisms for MMR vaccine induced neuroimmune

dysfunction. Finally, after nearly a decade of persecution for conducting

scientific research that questions the scientific and moral integrity of

one-size-fits-all mass vaccination policies, Andy Wakefield's accusers are

taking him to their own Medical Court. In a final attempt to silence him,

they want to take away his medical license and his ability to care for

vaccine injured children.

The BBC in London said the General Medical Council is charging Dr.

Wakefield with carrying out " inadequately founded " research, failing to

obtain ethical committee approval before publishing, acquiring funding

improperly and subjecting children to 'unnecessary and invasive

investigations.'

A leading London newspaper, The Daily Mail, protested Dr. Wakefield's

treatment by the General Medical Council, saying " He had a duty to speak out

and now he is being made to suffer for it. His treatment by the GMC is

utterly unjust. If this preposterous body had existed 200 years ago,

defending the prevailing wisdom against new ideas, doctors would still be

treating illnesses by slitting their patients' veins. "

F.E. Yazbak, M.D., FAAP, a pediatrician and researcher of autoimmune

regressive autism and vaccine injury, has published an excellent analysis of

the scientific issues and political motives involved in Wakefield's

persecution at the hands of the medical hierarcrhy. Dr. Yazbak's article

" When Finding Nothing Is Wonderful " was first published on RedFlags on June

9, 2006. <http://www.redflagsdaily.com/yazbak/2006_jun09?from=0>

MMR doctor 'to face GMS charges'

http://news.bbc.co.uk/1/hi/health/5070670.stm

BBC

June 12, 2005

The doctor who first suggested a link between the MMR vaccine and autism is

to be charged with serious professional misconduct, it is reported.

The Independent newspaper reports that the General Medical Council will

accuse Mr Wakefield of carrying out " inadequately founded " research.

Vaccination rates fell sharply after Dr Wakefield questioned the safety of

MMR, raising fears of a measles epidemic.

His initial Lancet paper has since been disowned by the journal.

The editor admitted he would not have published the 1998 paper if he had

known about what he called a " fatal conflict of interest " .

Mr Wakefield was being paid to see if there was any evidence to support

possible legal action by a group of parents who claimed their children were

damaged by the vaccine. Some children were involved in both studies.

In addition ten doctors who co-authored the paper issued a statement in 2004

arguing there was insufficient evidence to draw the conclusion that the MMR

vaccine was not safe.

The main thrust of the paper was that MMR was linked not only to autism, but

also to the bowel disorder Crohn's disease. Small-scale US research has

subsequently produced similar findings.

No corroboration

But a host of major studies has since failed to find any evidence of a link

between MMR and autism.

However, the uptake rate for MMR - a triple jab which protects against

measles, mumps and rubella - slumped in the wake of the controversy.

The rate has since picked up again, but remains low in some areas of the

country, most notably London.

The number of confirmed measles cases in England and Wales rose from 56 in

1998 to 438 in 2003, although the provisional figure for 2005 was back down

to 77.

The Independent reports that Mr Wakefield will face four charges: that he

published inadequately founded research, failed to obtain ethical committee

approval for the work, obtained funding for it improperly, and subjected

children to " unnecessary and invasive investigations " .

The paper says that detailed charges are being formulated by the GMC's

lawyers, and will be presented in the autumn, with a public hearing expected

next year.

If found guilty, Mr Wakefield could be struck off the medical register.

Mr Wakefield carried out his initial study while working at London's Royal

Free Hospital.

He has since moved to the US.

A General Medical Council spokesperson refused to confirm details, but said:

" An investigation is ongoing. "

She said the council had been investigating Mr Wakefield since The Lancet

issued its retraction in 2004.

She added that any charges against him might " evolve " before they were

formally presented.

----------------------------------------------------------------------------

MMR and a doctor only doing his duty

http://www.dailymail.co.uk/pages/live/articles/news/newscomment.html?in_arti

cle_id=390366 & in_page_id=1787 & in_a_source=

Daily Mail - UK

13th June 2006

Nobody has complained to the General Medical Council about Dr

Wakefield. Nobody has suggested that he said or wrote anything dishonest

when he believed he had discovered a link between the MMR vaccine and

autism.

Yet the GMC has taken it upon itself to charge him with serious professional

misconduct, threatening to strike him off, and, in doing so, destroy his

livelihood.

His research was 'inadequately founded', say the charges. He failed to

obtain ethical committee approval before publishing, acquired funding

improperly and subjected children to 'unnecessary and invasive

investigations'.

In short, the council is throwing the book at him. Why?

The case has the whiff about it of a medieval inquisition, called to defend

the orthodoxy of the establishment against the heresy of an independent

mind.

Dr Wakefield's 'crime' was to open an important debate that remains

unresolved. Eight years on, he is by no means alone among doctors in

believing that he may have been on to something. The trouble is we just

don't know.

Even Tony Blair, though publicly committed to the triple vaccine, seems to

have private doubts. What else would explain why he has refused to tell MPs

if his son Leo has been given it?

After all, he has never been above dragging his family into the spotlight,

when it suits his political purposes.

The GMC's real beef against Dr Wakefield is that immunisation rates fell —

and cases of measles, mumps and rubella rose — after his article appeared.

But that is hardly his fault. It is the fault of a Government that refused

to heed parents' fears, and failed to offer separate vaccines on the NHS,

even though the cost implications were marginal.

Think what an uproar there would be today if it was discovered that Dr

Wakefield had kept his suspicions to himself and a link had subsequently

been proven. He had a duty to speak out — and now he is being made to suffer

for it.

His treatment by the GMC is utterly unjust. If this preposterous body had

existed 200 years ago, defending the prevailing wisdom against new ideas,

doctors would still be treating illnesses by slitting their patients' veins.

----------------------------------------------------------------------------

------------------------

FIRST PUBLISHED ON REDFLAGS ON JUNE 9, 2006

<http://www.redflagsdaily.com/yazbak/2006_jun09?from=0>

F. E. Yazbak, a pediatrician, now devotes his time to the research of

autoimmune regressive autism and vaccine injury.

When Finding Nothing Is Wonderful

By F. Yazbak, MD, FAAP

Scientists are expected to discover things. They are applauded when they do

and sometimes ostracized when they don’t.

Mainstream researchers investigating the connection between autism and the

measles-mumps-rubella (MMR) vaccine, however, seem pleased when they find

nothing. They hurry to publish their “findings” to the jubilation of

“authorities.”

Repeating the performance a few times further cements the belief that if

“orthodox” first-class researchers cannot find a connection between the

triple vaccine, the measles virus and regressive autism, then, indeed, none

exists.

* * * *

There was a big commotion in the U.K. last month, when new research from the

United States seemed to confirm the presence of intestinal findings in

children with regressive autism, which were similar to those reported by

Wakefield, MD, in 1998.

On May 28, Sally Beck of The Mail on Sunday wrote a long article on the

study at Wake Forest University School of Medicine in North Carolina titled

“Scientists fear MMR link to autism.”

In the American study, 275 children with regressive autism and bowel disease

were evaluated. Of the 82 children completely tested, 70 proved positive for

the measles virus. Beck quoted , MD, the team leader as

saying, “Of the handful of results we have in so far, all are vaccine strain

and none are wild measles. This research proves that in the gastrointestinal

tract of a number of children, who have been diagnosed with regressive

autism, there is evidence of measles virus.” (1)

Several other Sunday papers reported the story in the U.K., while not much

about the Wake Forest research was mentioned in the American media.

On May 31, as if on cue, Reuters Health Information in New York published an

account of a different study headlined “No Evidence of Measles Virus in

MMR-Vaccinated Autistic Children.” It said “contrary to the findings of some

earlier studies, measles virus genetic material was not detected in the

blood of MMR-vaccinated autistic children with development regression,

according to a report in the Journal of Medical Virology for May.” (2)

The Reuters report went on, “In the present study, Dr. M.A. Afzal, from the

National Institute for Biological Standards and Control in Hertfordshire,

U.K., and colleagues used several assays to test for measles genome

sequences in leukocyte preparations obtained from 15 children with autism

who had received the MMR vaccine as part of the routine immunization

schedule in the U.K.”

According to the British researchers, there was no evidence of measles

genomic fragments in any of the children examined, in spite of the fact that

the methods used were " highly sensitive, specific, and robust " and capable

of detecting " measles virus RNA down to single figure copy numbers per

reaction. "

The Reuters’ report ended reassuringly: “Given the rigorous methods

employed, the researchers believe that measles virus material genuinely did

not exist in the patient's blood samples.”

Two friends, one in Wisconsin and the other in California, both very

informed about vaccine and autism matters, wrote to me almost simultaneously

asking the same question: “Can this really be a coincidence?” that we have a

study published supporting the MMR-autism connection and almost immediately

another contradicting it?

I answered them that I did not know for sure but that in the past, “Dr. M.A.

Afzal, from the National Institute for Biological Standards and Control in

Hertfordshire, U.K.” had published several articles that seemed

strategically very well-timed.

The differences between the two recent studies deserve repeating:

In the U.S. study, measles virus genomic RNA was actually found in the gut

of 70 affected children and the viral results of another 200 children with

typical gut pathology are still pending.

In the U.K. study, the researchers “could not detect” measles virus genetic

material in the blood of 15 MMR-vaccinated children with autism.

It is essential to also point out that the above-mentioned M.A. Afzal is not

N.A. Afzal, a pediatric gastroenterologist attached to the Centre for

Pediatric Gastroenterology at The Royal Free Hospital, London, U.K.

It was at the Royal Free Hospital that Wakefield practiced

gastroenterology for years and where he was the shining star before he dared

to “rock the boat” and was forced to resign. It is also at the Royal Free

and University College Medical School in London that Brent , one of

Wakefield’s most vocal critics, is professor of community pediatrics.

N.A. Afzal published his first study with the Royal Free team in December

2002. (3) He published two more studies in 2004 and one in 2005. (4) The

abstracts of all four studies did not contain any reference to autism and

vaccines.

M.A. Afzal, on the other hand, is a member of the virology department at the

National Institute for Biological Standards and Control (NIBSC). The

Institute is a respected multi-disciplinary scientific establishment with

national and international roles in the standardization and control of

biological substances including viral and bacterial vaccines. Since 1976,

the institute has been directly funded by the United Kingdom Health

Departments.

Members of the U.K. Health Departments have led the charge against Wakefield

and his theory and have spent enormous amounts of money on an MMR awareness

campaign. , Director of the U.K. Health Protection Agency’s

immunization department, co-authored, with , several anti-Wakefield

studies.

But back to M.A. Afzal of the NIBSC, who according to Reuters was certain in

2006 that the measles virus material genuinely did not exist in the patients

’ blood samples because he and his team did not find it. He must have been

aware that a Japanese team from Tokyo University led by H. Kawashima had

found the same “genetic material” in the blood of children with autism in

2000: “In order to characterize the strains that may be present, we have

carried out the detection of measles genomic RNA in peripheral mononuclear

cells (PBMC) in eight patients with Crohn's disease, three patients with

ulcerative colitis, and nine children with autistic enterocolitis...”

Kawashima discovered and reported that “the sequences obtained from the

children with autism were consistent with being vaccine strains” and that

the results were concordant with the exposure history of those children. (5)

So how come Team Tokyo found vaccine-strain measles virus genomic RNA in

peripheral mononuclear cells of vaccinated autistic children in 2000 and

Team U.K. found nothing in 2006?

The answer to that perplexing and rather sensitive question may be in a very

interesting study that was published in the Journal of Medical Virology in

May 2003, titled appropriately “Comparative evaluation of measles

virus-specific RT-PCR methods through an international collaborative study”

and authored by both Afzal and Kawashima, in addition to renowned experts

A.D. Osterhaus, S.L. Cosby, L. Jin, J. Beeler and K. Takeuchi. (6)

That international panel found, “Comparison of RT-PCR assays established in

house at various places revealed that laboratories could differ in

sensitivity by as much as 1,000-fold in terms of the ability to detect

measles virus sequences in clinical samples. The study indicates that PCR

findings, positive or negative, are questionable if they are not supported

by the associated data demonstrating the overall sensitivity of the assay

applied. Measles virus-specific RT-PCR-based assays need to be validated

using standard virus preparation or nucleic acid-based target templates. A

correlation between real-time quantitative PCR and the conventional PCR for

measles virus is highly desirable.”

The above is simply noted with interest.

Coincidence after coincidence

Wakefield published his now famous article, “Ileal-lymphoid-nodular

hyperplasia, non-specific colitis, and pervasive developmental disorder in

children,” in The Lancet on Feb. 28, 1998. (7)

Before that date, M.A. Afzal published a total of 16 studies and was the

lead author in nine of them. Twelve works were about mumps and four dealt

with assorted virology topics. Afzal did not write a single article or

publish any research dealing with measles, MMR, autism, inflammatory bowel

disease or related subjects before Wakefield’s landmark article.

Since Feb. 28, 1998, M.A. Afzal has published 20 articles: 13 were about

measles, MMR and related topics; six dealt with mumps; and one was on other

viral topics. He was lead author in 13 of the 20.

The first Afzal paper on the topic of measles titled “Absence of

measles-virus genome in inflammatory bowel disease” was also published in

the February 28, 1998 issue of the Lancet, five pages after Wakefield’s

article. (8)

An abstract of the Afzal research was not available for quoting, but it

appears from the title that the virologist and his colleagues at the NIBSC

did not find measles-virus genome in patients with inflammatory bowel

disease.

Measles infection and inflammatory bowel disease

In the summer of 1998, Balzola, Khan, Pera, Bonino, Pounder and Wakefield

reported measles IgM immunoreactivity in patients with inflammatory bowel

disease (IBD). Their research revealed specific and fluctuating immune

response to measles virus in patients with Crohn's disease and ulcerative

colitis. (9)

Afzal and colleagues published “Absence of detectable measles virus genome

sequence in inflammatory bowel disease tissues and peripheral blood

lymphocytes” in the Journal of Medical Virology. (10) According to the

authors, in spite of using a “highly sensitive measles-specific

RT-PCR-nested PCR system,” they failed to detect the presence of measles

virus in 93 colon biopsies and 31 peripheral blood lymphocyte preparations,

examined and obtained from patients with IBD and non-inflammatory controls.

It seems from the above that M.A. Afzal was looking for evidence of viral

presence in the colon (large intestine) and did not find any. Wakefield had

better luck, a little later, when he looked for such evidence in the ileum.

Afzal was certainly aware that the children tested by the Royal Free Team

had ileal lymphonodular hyperplasia.

In virology, as in life, it’s always better to look in the right spot.

The fact that Afzal could not find evidence of measles genomic RNA in the

peripheral blood in 1998 is not surprising. Eight years later, as noted

earlier, he still can’t.

Measles virus and Crohn’s disease

In April 1999, Wakefield, Montgomery and Pounder published “Crohn's disease:

the case for measles virus.” (11) They reported, “We and others have

suggested that measles virus may be causally related to Crohn's disease, and

that the associated risk is an atypical pattern of exposure.… The data for

Crohn's disease suggest that persistent infection may follow early low dose

exposure and low zone immunological tolerance. The changing pattern of

measles virus exposure this century would be consistent with a shift toward

lower dose of infection. Such an exposure would also be consistent with

persistence of the virus at very low copy number within discrete foci of

granulomatous inflammation….”

Afzal, Minor, Armitage and Gosh published “Measles virus and Crohn's

disease” in June of the same year. (12) An abstract of the publication is

not available for review but the similarity of the two titles is simply

astonishing.

2000: MMR safety review

In their careful and detailed scholarly article on MMR safety, “Measles,

mumps, rubella vaccine: through a glass, darkly,” (13) Wakefield and

Montgomery reviewed the safety testing of MMR vaccine or lack thereof.

In “Clinical safety issues of measles, mumps and rubella vaccines,” (14)

Afzal, Minor and Schild did not directly respond but essentially reviewed

all the studies that had been done by the anti-Wakefield camp and had failed

to identify the presence of measles virus genomic RNA in patients with IBD.

In the available abstract, M.A. Afzal stated, “Based on the published data

reviewed here, it can be concluded that there is no direct association

between measles virus or measles vaccines and the development of Crohn’s

disease, a conclusion which is supported by most epidemiological findings.”

The above statement obviously can be correct. On the other hand, presuming

that because the studies reviewed did not reveal a relationship between

measles vaccine and IBD that none exists appears somewhat presumptuous.

As to the safety of the MMR vaccine, one need only mention one of the

conclusions of the recent comprehensive Cochrane MMR Review: “The design and

reporting of safety outcomes in MMR vaccine studies, both pre- and

post-marketing, are largely inadequate.”

April 2002

In “Potential viral pathogenic mechanism for new variant inflammatory bowel

disease,” Uhlmann and associates, including Wakefield, published results of

their meticulous research. It revealed that “75 of 91 patients with a

histologically confirmed diagnosis of ileal lymphonodular hyperplasia and

enterocolitis were positive for measles virus in their intestinal tissue

compared with five of 70 control patients. Measles virus was identified

within the follicular dendritic cells and some lymphocytes in foci of

reactive follicular hyperplasia. The copy number of measles virus ranged

from one to 300,00 copies/ng total RNA.” The authors concluded, “The data

confirm an association between the presence of measles virus and gut

pathology in children with developmental disorder.” (15)

M.A. Afzal and associates did not immediately respond. Instead, they

published two well-written but highly technical papers on the

newest-available, very delicate PCR testing procedures. The 2003 publication

was discussed earlier. (5) The second, published in the Journal of Medical

Virology in May 2004, is listed for completion. (16)

The Afzal group response to the 2002 Uhlmann paper seems to be the most

recently published study (May 2006) in the Journal of Medical Virology. It

was reported by Reuters and discussed earlier. (17)

“Leukocyte preparations from children with documented evidence of MMR

vaccination and confirmed diagnosis of autism were examined by several

assays designed to target multiple regions of the measles virus genome

sequence. No sample was found positive by any method. The assays applied

were highly sensitive, specific and robust in nature, and were based on the

amplification of measles virus RNA transcripts by real-time quantitative

RT-PCR (QRT-PCR) as well as by conventional RT-PCR-nested PCR. The assays

applied were potentially able to detect measles virus RNA down to single

figure copy numbers per reaction. The amount of total nucleic acid extract

of leukocytes subjected to various measles virus-specific investigations was

several-fold higher than minimally required of a sample where measles virus

persistence is well documented. This study failed to substantiate reports of

the persistence of measles virus in autistic children with development

regression.”

Again one should mention that M.A. Afzal and associates investigated only 15

children with autism “who had received the MMR vaccine as part of the U.K.

routine immunization schedule.” If these children had early-onset autism and

happened, as clearly stated, simply to have “received the MMR vaccine as

part of the U.K. routine immunization schedule,” they may not necessarily ha

ve the typical findings of autistic enterocolitis.

The children in the Wakefield studies have regressive autism, a totally

different entity; in most, the very clear regression seemed to have been

chronologically related to their MMR vaccination.

Conclusions

This review cannot ascertain whether the recent publication by M.A. Afzal

and associates (17) was a response to the 2002 study by Uhlmann et al (15)

or was intended to pre-empt the recent important report from Wake Forest

University.

It does demonstrate, on the other hand, a sudden and intense interest on the

part of Afzal in measles virus genomic RNA, the MMR vaccine, autism and

inflammatory bowel disease starting in 1998.

As more future studies supporting and confirming the Wakefield findings are

published in the U.S. and elsewhere, it would not be surprising if M.A.

Afzal and his associates continued their sophisticated research and still

found nothing, as they have all along.

Future publications by the group will be celebrated by the vaccine

authorities and medical groups, as long as they continue to report negative

findings.

The medical authorities will undoubtedly declare that because Afzal and

friends found nothing, there was, indeed, nothing and, therefore, that the

measles virus and the MMR vaccine are not in any way responsible for the

sudden regression of a small percentage of children, who are genetically

predisposed to autism.

And that would be truly tragic.

References

Sally Beck. “Scientists fear MMR link to autism.” Mail on Sunday. May 28,

2006. Available at http://tinyurl.com/zjbsa

“No Evidence of Measles Virus in MMR-Vaccinated Autistic Children.” Reuters

Health Report, New York. June 30, 2006. Available at

http://www.medscape.com/viewarticle/533545

Afzal NA, Addai S, Fagbemi A, Murch S, Thomson M, Heuschkel R Refeeding

syndrome with enteral nutrition in children: a case report, literature

review and clinical guidelines. Clin Nutr. 2002 Dec;21(6):515-20. PMID:

12468372

Afzal NA, Davies S, Paintin M, Arnaud-Battandier F, - JA, Murch

S, Heuschkel R, Fell J. Colonic Crohn's disease in children does not respond

well to treatment with enteral nutrition if the ileum is not involved. Dig

Dis Sci. 2005 Aug; 50(8): 1471-5. PMID: 16110838

Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A.

Detection and sequencing of measles virus from peripheral mononuclear cells

from patients with inflammatory bowel disease and autism. Dig Dis Sci. 2000

Apr; 45(4): 723-9.

Afzal MA, Osterhaus AD, Cosby SL, Jin L, Beeler J, Takeuchi K, Kawashima

H.Comparative evaluation of measles virus-specific RT-PCR methods through an

international collaborative study. J Med Virol. 2003 May; 70(1): 171-6.

PMID: 12629660

Wakefield AJ, Murch SH, A, Linnell J, Casson DM, Malik M, Berelowitz

M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, -

JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive

developmental disorder in children.

Lancet. 1998 Feb 28; 351(9103): 637-41

Afzal MA, Minor PD, Begley J, Bentley ML, Armitage E, Ghosh S, Ferguson A.

Absence of measles-virus genome in inflammatory bowel disease. Lancet. 1998

Feb 28; 351(9103): 646-7. PMID: 9500326

Balzola FA, Khan K, Pera A, Bonino F, Pounder RE, Wakefield AJ. Measles IgM

immunoreactivity in patients with inflammatory bowel disease. Ital J

Gastroenterol Hepatol. 1998 Aug; 30(4): 378-82. PMID: 9789132

Afzal MA, Armitage E, Begley J, Bentley ML, Minor PD, Ghosh S, Ferguson A.

Absence of detectable measles virus genome sequence in inflammatory bowel

disease tissues and peripheral blood lymphocytes.

J Med Virol. 1998 Jul; 55(3): 243-9.

Wakefield AJ, Montgomery SM, Pounder RE. Crohn's disease: the case for

measles virus. Ital J Gastroenterol Hepatol. 1999 Apr; 31(3): 247-54.

Review. PMID: 10379489

Afzal MA, Minor PD, Armitage E, Ghosh S. Measles virus and Crohn's disease.

Gut. 1999 Jun; 44(6): 896-7. PMID: 10375297

Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: through a

glass, darkly. Adverse Drug React Toxicol Rev. 2000 Dec; 19(4): 265-83;

discussion 284-92. Review. PMID: 11212459

Afzal MA, Minor PD, Schild GC. Clinical safety issues of measles, mumps and

rubella vaccines. Bull World Health Organ. 2000; 78(2): 199-204. Review.

PMID: 10743285

Uhlmann V, CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB,

- J, Thomson M, Wakefield AJ, O'Leary JJ. Potential viral

pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol.

2002 Apr; 55(2): 84-90. PMID: 11950955

Ozoemena LC, Minor PD, Afzal MA. Comparative evaluation of measles virus

specific TaqMan PCR and conventional PCR using synthetic and natural RNA

templates. J Med Virol. 2004 May; 73(1): 79-84. PMID: 15042652

Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD.

Absence of detectable measles virus genome sequence in blood of autistic

children who have had their MMR vaccination during the routine childhood

immunization schedule of U.K. J Med Virol. 2006 May; 78(5): 623-30. PMID:

16555271

=============================================

News@... is a free service of the National Vaccine Information

Center and is supported through membership donations. Learn more about

vaccines, diseases and how to protect your informed consent rights

http://www.nvic.org

Become a member and support NVIC's work

https://www.nvic.org/making%20cash%20donations.htm

To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm

[Guest guest]

It sais that the GMC and the BBC are charging A. Wakefied with professional

misconduct; what on earth have the BBC to do with all this? When I read this, I

thought the BBC are supposed to be totally impartial. They don't seem to be,

when reading this. Or am I totally misunderstanding this?

If this is right, I will change my view of the BBC and will know that they are

just under our UK governments thumb, like many other organizations and charities

in the UK.

Ingrid

[Guest guest]

Ingrid, it says:

" The BBC in London said the General Medical Council is charging Dr.

Wakefield with carrying out " inadequately founded " research, failing to

obtain ethical committee approval before publishing, acquiring funding

improperly and subjecting children to 'unnecessary and invasive

investigations.' "

Where does it say the BBC are charging him? They cannot - they have no

power to.

Sue

Re: [NVIC] UK Docs Attack Wakefield

It sais that the GMC and the BBC are charging A. Wakefied with professional

misconduct; what on earth have the BBC to do with all this? When I read

this, I thought the BBC are supposed to be totally impartial. They don't

seem to be, when reading this. Or am I totally misunderstanding this?

If this is right, I will change my view of the BBC and will know that they

are just under our UK governments thumb, like many other organizations and

charities in the UK.

Ingrid